Another month, another slide show. This one is about two things I had no experience with prior to fellowship—interleukin 15 and chondrosarcoma.

The latter should be better known to surgeons, as most are resistant to all known types of chemotherapy or radiation. The only good way to get rid of them, then, is surgery. Which is fortunate, as they are usually very slow growing. Spoiler alert: our patient’s wasn’t.

Interleukin 15 should, in theory, have most of the benefits of interleukin 2 without the common side-effects of hypotension, hypoxia, and feeling like a steamroller ran over you. The not having adverse effects part has so far been true. Waiting to see what the outcomes are.

You can view a full-screen version of the slides here.

Error: Embedded data could not be displayed.